Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane
- PMID: 16359182
- DOI: 10.1021/tx0502138
Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane
Abstract
The chemopreventive agent sulforaphane is an isothiocyanate derived from cruciferous vegetables. Sulforaphane exerts cancer chemopreventive effects by inducing antioxidant/electrophile response element (ARE)-regulated phase 2 enzyme and antioxidant genes through activation of the transcription factor nuclear factor-E2-related factor 2 (Nrf2), which is regulated by the thiol-rich sensor protein Kelch-like ECH-associated protein 1 (Keap1). Sulforaphane is an electrophile that can react with protein thiols to form thionoacyl adducts. We hypothesized that, like other electrophilic Nrf2 activators, sulforaphane activates this system through specific modifications of the Keap1 protein. However, thionoacyl adducts are labile to hydrolysis and transacylation reactions, which complicate the identification of the sulforaphane adduct sites on Keap1. In this study, we characterized the stability of sulforaphane thionoacyl adducts and developed a liquid chromatography-tandem mass spectrometry method to map labile sulforaphane adduct sites formed on Keap1 in vitro. Sulforaphane displays a distinctly different pattern of Keap1 modification than previously studied ARE inducers that modify Keap1 by alkylation. Sulforaphane modified Keap1 most readily in the Kelch domain, rather than in the central linker domain, which is targeted by previously characterized ARE inducers. Also, in contrast to previously studied ARE inducers and as reported recently [Zhang, et al. (2005) J. Biol. Chem. 280, 30091-30099], sulforaphane treatment in vivo does not lead to the accumulation of ubiquitinated Keap1. Our observations suggest a novel mechanism for Nrf2 stabilization by sulforaphane-Keap1 thionoacyl adduct formation.
Similar articles
-
Keap1-nrf2 signaling: a target for cancer prevention by sulforaphane.Top Curr Chem. 2013;329:163-77. doi: 10.1007/128_2012_339. Top Curr Chem. 2013. PMID: 22752583 Free PMC article. Review.
-
Regulation of the Keap1/Nrf2 system by chemopreventive sulforaphane: implications of posttranslational modifications.Ann N Y Acad Sci. 2011 Jul;1229:184-9. doi: 10.1111/j.1749-6632.2011.06092.x. Ann N Y Acad Sci. 2011. PMID: 21793854 Review.
-
Modification of keap1 cysteine residues by sulforaphane.Chem Res Toxicol. 2011 Apr 18;24(4):515-21. doi: 10.1021/tx100389r. Epub 2011 Mar 10. Chem Res Toxicol. 2011. PMID: 21391649 Free PMC article.
-
Heteroaromatic 4-arylquinols are novel inducers of nuclear factor-erythroid 2-related factor 2 (Nrf2).Eur J Pharmacol. 2010 Sep 25;643(2-3):188-94. doi: 10.1016/j.ejphar.2010.06.040. Epub 2010 Jun 30. Eur J Pharmacol. 2010. PMID: 20599909
-
Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2.Proc Natl Acad Sci U S A. 2005 Jul 19;102(29):10070-5. doi: 10.1073/pnas.0502402102. Epub 2005 Jul 8. Proc Natl Acad Sci U S A. 2005. PMID: 16006525 Free PMC article.
Cited by
-
Neuroprotective effect of acetoxypachydiol against oxidative stress through activation of the Keap1-Nrf2/HO-1 pathway.BMC Complement Med Ther. 2024 Apr 25;24(1):175. doi: 10.1186/s12906-024-04474-6. BMC Complement Med Ther. 2024. PMID: 38664646 Free PMC article.
-
Open-Label Sulforaphane Trial in FMR1 Premutation Carriers with Fragile-X-Associated Tremor and Ataxia Syndrome (FXTAS).Cells. 2023 Dec 5;12(24):2773. doi: 10.3390/cells12242773. Cells. 2023. PMID: 38132093 Free PMC article.
-
Ergothioneine and its congeners: anti-ageing mechanisms and pharmacophore biosynthesis.Protein Cell. 2024 Feb 29;15(3):191-206. doi: 10.1093/procel/pwad048. Protein Cell. 2024. PMID: 37561026 Free PMC article. Review.
-
Neural crest cells and fetal alcohol spectrum disorders: Mechanisms and potential targets for prevention.Pharmacol Res. 2023 Aug;194:106855. doi: 10.1016/j.phrs.2023.106855. Epub 2023 Jul 17. Pharmacol Res. 2023. PMID: 37460002 Free PMC article. Review.
-
A Point Mutation at C151 of Keap1 of Mice Abrogates NRF2 Signaling, Cytoprotection in Vitro, and Hepatoprotection in Vivo by Bardoxolone Methyl (CDDO-Me).Mol Pharmacol. 2023 Aug;104(2):51-61. doi: 10.1124/molpharm.123.000671. Epub 2023 May 15. Mol Pharmacol. 2023. PMID: 37188495 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials